KR100697936B1 - Granulated Anti-Inflammatory Composition - Google Patents
Granulated Anti-Inflammatory Composition Download PDFInfo
- Publication number
- KR100697936B1 KR100697936B1 KR1020050107854A KR20050107854A KR100697936B1 KR 100697936 B1 KR100697936 B1 KR 100697936B1 KR 1020050107854 A KR1020050107854 A KR 1020050107854A KR 20050107854 A KR20050107854 A KR 20050107854A KR 100697936 B1 KR100697936 B1 KR 100697936B1
- Authority
- KR
- South Korea
- Prior art keywords
- granulated
- inflammatory agent
- weight
- parts
- dextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000003110 anti-inflammatory effect Effects 0.000 title description 3
- 229920001353 Dextrin Polymers 0.000 claims abstract description 17
- 239000004375 Dextrin Substances 0.000 claims abstract description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000019425 dextrin Nutrition 0.000 claims abstract description 17
- 239000003599 detergent Substances 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000010457 zeolite Substances 0.000 claims abstract description 12
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 9
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000440 bentonite Substances 0.000 claims abstract description 6
- 229910000278 bentonite Inorganic materials 0.000 claims abstract description 6
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000004927 clay Substances 0.000 claims abstract description 5
- 229910052570 clay Inorganic materials 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 150000001450 anions Chemical class 0.000 claims abstract description 4
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- 150000001768 cations Chemical class 0.000 claims abstract description 4
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 52
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 37
- 229920002774 Maltodextrin Polymers 0.000 claims description 9
- 239000005913 Maltodextrin Substances 0.000 claims description 9
- 229940035034 maltodextrin Drugs 0.000 claims description 9
- 239000005909 Kieselgur Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 239000011269 tar Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- 239000002519 antifouling agent Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 238000005406 washing Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 239000004744 fabric Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 150000001204 N-oxides Chemical class 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 2
- KAYZUBWVKOKHES-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound [CH]=CC1=CC=NC=C1 KAYZUBWVKOKHES-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- LEYJJTBJCFGAQN-UHFFFAOYSA-N chembl1985378 Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=C(S(O)(=O)=O)C=C1 LEYJJTBJCFGAQN-UHFFFAOYSA-N 0.000 description 2
- BPHHNXJPFPEJOF-UHFFFAOYSA-J chembl296966 Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)C1=CC(S([O-])(=O)=O)=C(N)C2=C(O)C(N=NC3=CC=C(C=C3OC)C=3C=C(C(=CC=3)N=NC=3C(=C4C(N)=C(C=C(C4=CC=3)S([O-])(=O)=O)S([O-])(=O)=O)O)OC)=CC=C21 BPHHNXJPFPEJOF-UHFFFAOYSA-J 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- -1 white earth Chemical compound 0.000 description 2
- UDJZTGMLYITLIQ-UHFFFAOYSA-N 1-ethenylpyrrolidine Chemical compound C=CN1CCCC1 UDJZTGMLYITLIQ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920002245 Dextrose equivalent Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0021—Dye-stain or dye-transfer inhibiting compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/06—Powder; Flakes; Free-flowing mixtures; Sheets
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/02—Inorganic compounds ; Elemental compounds
- C11D3/12—Water-insoluble compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/22—Carbohydrates or derivatives thereof
- C11D3/222—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Detergent Compositions (AREA)
Abstract
Description
본 발명은 입자화된 이염방지제 조성물에 관한 것으로서, 보다 상세하게는 액상 이염방지제를 입자화하여 분말세제에 적용하기에 용이할 뿐만 아니라 이염방지 효과가 우수한 이염방지제 조성물에 관한 것이다.The present invention relates to a granulated anti-inflammation composition, and more particularly, to an anti-inflammation inhibitor composition excellent in not only easy to apply to a powder detergent by granulating the liquid anti-inflammation agent, but also excellent in the anti-inflammation effect.
이염방지제는 염료가 의류로 이전하여 의류의 색상이 변하는 것을 방지하는 물질로서 일반적 세탁용 세제에 포함되어 널리 사용된다. 사용되고 있는 이염방지제로는 PVP(폴리비닐피롤리딘), PVP/PVI(n-비닐피롤리딘 및 n-비닐이미다졸), PVNO(폴리비닐피리딘N-옥사이드) 등이 있으며, ISP사와 BASF사에서 시판하고 있다. 이염방지제에 대해서는 PCT특허 WO 95/03390, 미국특허 제5,604,197호, 제5,458,809호, 제5,466,802호, 제5,627,151호 등에 잘 기술되어 있다.Anti-inflammatory agents are widely used in general laundry detergents as a material to prevent the transfer of the dye to the clothes to change the color of the clothes. Anti-inflammatory agents used include PVP (polyvinylpyrrolidine), PVP / PVI (n-vinylpyrrolidine and n-vinylimidazole), PVNO (polyvinylpyridine N-oxide), and ISP and BASF. It is marketed by company. Anti-inflammatory agents are well described in PCT patents WO 95/03390, US Pat. Nos. 5,604,197, 5,458,809, 5,466,802, 5,627,151 and the like.
이러한 이염방지제 화합물들은 원료성상이 액상인 관계로 세제의 분말성상 특성을 저하시킬 우려가 있으며, 그에 따라 분말세제의 흐름성 저하, 제품의 덩어리짐, 제품의 혼합균일성 저하 등의 문제점이 생길 수 있다. 이와 같은 이유로 인하여, 분말세제에 포함되는 이염방지제는 입자화되는 것이 바람직하며, 입자화하는 경우 이염방지제의 이염방지 효과뿐만 아니라 분말세제의 전체적 세정력에 미치는 영향 또한 면밀히 고려되어야 한다.These anti-infective compounds may reduce the powder properties of the detergent due to the liquid phase of the raw material, and thus may cause problems such as deterioration of the flowability of the powder detergent, agglomeration of the product, and deterioration of the mixing uniformity of the product. have. For this reason, it is preferable that the anti-inflammation agent included in the powder detergent is granulated, and the effect on the overall detergency of the powder detergent as well as the anti-drinking effect of the anti-inflammation agent should be carefully considered.
위와 같은 적용상의 난점으로 인해 이염방지제의 입자화에 대한 노력은 계속되고 있다. 예를 들어, 미국특허 제5,869,442호, 제6,117,834호, 제6,274,664호 및 유럽특허 제677,580호에 이러한 문제점을 개선하는 방법이 개시되어 있으며, 구체적으로 미국특허 제6,117,834호는 제올라이트를 사용하여 입자화된 이염방지제 조성물을 개시하고 있고, 미국특허 제6,274,664호는 실리카를 사용하여 입자화된 이염방지제 조성물을 개시하고 있다. 그러나, 제올라이트 또는 실리카를 이용한 이염방지제 조성물은 이염방지제를 다량 함유할 수 없어 프리 담체(free carrier)가 많이 발생하게 되므로 경제성과 이염방지 효과가 저하되는 문제점이 있으며, 특히 미국특허 제6,274,664호에 따른 실리카가 사용된 입자화는 제조비용이 매우 높고 수율이 매우 낮다는 문제가 있어 제품화가 어렵다.Due to the above-mentioned application difficulties, efforts for the granulation of anti-inflammatory agents continue. For example, US Pat. Nos. 5,869,442, 6,117,834, 6,274,664, and European Patent 677,580 disclose methods of ameliorating these problems, and specifically US Pat. No. 6,117,834 is used to formulate particles using zeolites. An anti-inflammatory composition is disclosed, and US Pat. No. 6,274,664 discloses an anti-inflammatory composition granulated using silica. However, since the anti-deposition agent composition using zeolite or silica cannot contain a large amount of anti-deposition agent, a lot of free carriers are generated, so that there is a problem in that economical and anti-deposition effect is reduced, in particular, according to US Patent No. 6,274,664. Granulation with silica is difficult to commercialize due to the problem that the manufacturing cost is very high and the yield is very low.
또한 한국특허출원 출원번호 제10-2003-0062823호, 제10-2003-0062824호 및 제10-2003-0071569호에 개시된 이염방지제의 입자화 및 이를 적용한 조성물들은 이염방지 효과 및 제품의 안정성이 향상되었으나, 이러한 분말세제 조성물은 사용시 전체적 세탁 효과가 떨어지는 문제점이 있다. 즉, 상기 기술들에서 이염방지제를 입자화하기 위해 사용된 물질은 무기물인 실리카 또는 규조토인데, 이들은 의류 세탁 시 잔존하게 되어 전체적 세탁 효과를 떨어뜨리는 문제가 있다. 특히, 한국에서는 계절특성상 겨울의 수온이 0℃ 근처까지 떨어져 저온세탁을 하는 경우가 많은데, 이때 이염방지제는 세탁물에 잔존하고 이염방지의 효과를 제대로 발현하지 못하게 된다.In addition, the particles of the anti-inflammation agent disclosed in the Korean Patent Application Nos. 10-2003-0062823, 10-2003-0062824 and 10-2003-0071569 and the compositions applied thereto have improved anti-degradation effect and stability of the product. However, such a powder detergent composition has a problem in that the overall washing effect is lowered during use. In other words, the materials used to granulate the anti-inflammatory agent in the above techniques are inorganic silica or diatomaceous earth, which remain when washing clothes, thereby degrading the overall washing effect. In particular, due to seasonal characteristics, winter water temperature drops to near 0 ° C., so that low-temperature washing is often performed. At this time, the anti-inflammatory agent remains in the laundry and does not properly express the effect of anti-dyeing.
따라서 본 발명이 이루고자 하는 기술적 과제는 상기 문제점을 해결하여 액상의 이염방지제를 입자화하여 분말세제에 적용하기 용이할 뿐만 아니라 이염방지 효과가 우수하며, 물에 대한 용해성이 우수하여 세탁 후 의류에 잔존하지 않고 이염방지제의 함유율이 높아 제조비용 및 수율이 개선된 입자화된 이염방지제 조성물을 제공하는데 있다.Therefore, the technical problem to be solved by the present invention is to solve the above problems, to form a liquid anti-inflammation agent to make it easy to apply to a powder detergent, as well as excellent anti-inflammation effect, excellent solubility in water and remaining in clothes after washing Without the high content of the anti-inflammatory agent is to provide a granulated anti-inflammatory agent composition with improved manufacturing cost and yield.
전술한 기술적 과제를 달성하기 위하여, 본 발명은 분말세제에 적용하기 적합한 입자화된 이염방지제 조성물로서, 하기 화학식 1로 표시되는 이염방지제 및 덱스트린(dextrin)을 포함하는 것을 특징으로 하는 이염방지제 조성물을 제공한다.In order to achieve the above technical problem, the present invention is a granulated anti-inflammatory agent composition suitable for application to a powder detergent, anti-inflammation agent composition characterized in that it comprises an anti-inflammatory agent and dextrin represented by the formula (1) to provide.
상기 화학식 1에서, m은 중합도를 의미하며, X-는 음이온이고, M+은 양이온이며, R1 및 R2는 각각 수소, 알킬기 또는 아릴기이고, n은 1부터 5까지의 정수이다.In Chemical Formula 1, m means a degree of polymerization, X− is an anion, M + is a cation, R 1 and R 2 are each hydrogen, an alkyl group or an aryl group, and n is an integer of 1 to 5.
보다 바람직하게, 본 발명은 분말세제에 적용하기 적합한 입자화된 이염방지 제 조성물로서, 상기 화학식 1로 표시되는 이염방지제 5 내지 80 중량부; 덱스트린 10 내지 90 중량부; 및 제올라이트, 백토, 벤토나이트, 타르크, 규조토 및 이들의 혼합물로 이루어진 군으로부터 선택된 물질 0 내지 30 중량부;를 포함하는 것을 특징으로 하는 입자화된 이염방지제 조성물을 제공한다.More preferably, the present invention is a granulated anti-inflammatory agent composition suitable for application to a powder detergent, 5 to 80 parts by weight of an anti-inflammatory agent represented by the formula (1); 10 to 90 parts by weight of dextrin; And 0 to 30 parts by weight of a material selected from the group consisting of zeolite, clay, bentonite, tar, diatomaceous earth, and mixtures thereof.
보다 바람직하게, 본 발명은 상기 덱스트린이 말토덱스트린인 것을 특징으로 하는 입자화된 이염방지제 조성물을 제공한다.More preferably, the present invention provides a granulated anti-inflammatory agent composition, characterized in that the dextrin is maltodextrin.
이하, 본 발명의 입자화된 이염방지제 조성물에 대하여 상세히 설명한다.Hereinafter, the granulated anti-inflammatory agent composition of the present invention will be described in detail.
본 발명의 입자화된 이염방지제 조성물은 하기 화학식 1로 표시되는 이염방지제를 포함한다.The granulated anti-inflammation agent composition of the present invention includes an anti-inflammation agent represented by the following formula (1).
<화학식 1><Formula 1>
상기 화학식 1에서, m은 중합도를 의미하며, X-는 음이온이고, M+은 양이온이며, R1 및 R2는 각각 수소, 알킬기 또는 아릴기이고, n은 1부터 5까지의 정수이다.In Chemical Formula 1, m means a degree of polymerization, X− is an anion, M + is a cation, R 1 and R 2 are each hydrogen, an alkyl group or an aryl group, and n is an integer of 1 to 5.
상기 화학식 1과 같은 이염방지제로는 ISP사에서 제품으로 생산되고 있는 폴리비닐 피리딘엔옥사이드인 [4-Ethenyl pyridine, homopolymer, N-oxide; aqueous solution]를 들 수 있고, 이 외에 비닐 피롤리돈, 비닐 이미다졸 및 비닐 피리딘 엔 옥사이드의 중합체들이 하나 이상 더 첨가될 수 있다.Examples of the anti-inflammatory agent such as Chemical Formula 1 include polyvinyl pyridineene oxide [4-Ethenyl pyridine, homopolymer, N-oxide; aqueous solution], in addition, one or more polymers of vinyl pyrrolidone, vinyl imidazole and vinyl pyridine end oxide may be added.
본 발명의 입자화된 이염방지제 조성물은 덱스트린을 포함한다. 덱스트린은 녹말을 가수분해 할 때 그 중간과정에서 발생하는 것으로 맥아당 또는 포도당이 되지 못한 물질이며 보통 호정(糊精)이라고도 부른다. 이것은 산(酸)이나 아밀라아제를 반응시켜 얻어내며, 백색 또는 황색을 띠고 있는 분말로서 물, 알코올 등에 용해되는 성질을 갖고 있다.The granulated anti-inflammatory agent composition of the present invention comprises dextrin. Dextrin, which occurs during the process of hydrolysis of starch, does not become maltose or glucose and is also called hojeong. It is obtained by reacting acid or amylase. It is white or yellow powder and dissolves in water, alcohol and the like.
본 발명은 덱스트린을 담체로 액상의 이염방지제를 입자화시킬 경우 전술한 문제점을 해결하여 목적하는 기술적 과제를 달성할 수 있다는 놀라운 사실에 기초한다. 즉, 덱스트린으로 이염방지제를 입자화시킨 이염방지제 조성물은 분말세제에 적용하기 용이할 뿐만 아니라 이염방지 효과가 우수하며, 물에 대한 용해성이 우수하여 세탁 후 의류에 잔존하지 않고 이염방지제의 함유율이 높아 제조비용 및 수율이 개선된다.The present invention is based on the surprising fact that when the dextrin is used as a carrier to granulate a liquid anti-inflammatory agent, the above-mentioned problems can be solved to achieve the desired technical problem. In other words, the anti-inflammation agent composition in which the anti-inflammation agent is granulated with dextrin is not only easy to apply to the powder detergent, but also has an excellent anti-inflammation effect. Manufacturing costs and yields are improved.
본 발명에서 사용된 덱스트린으로 말토덱스트린이 사용되는 것이 보다 바람직하며, 말토덱스트린은 DE20 미만(dextrose equivalent, 고형분 중의 글루코스로 환산한 직접환원당 백분율을 의미하며, 글루코스가 100임)의 전분 가수분해물로 전분과 물엿 사이의 물성을 가진 분말이다. 말토덱스트린은 흡유능이 우수하고, 냉수에 완전히 용해되며, 흡습이 되기 어려워 조해나 케이킹이 방지된다.Maltodextrin is more preferably used as the dextrin used in the present invention, and maltodextrin is starch as a starch hydrolyzate of less than DE20 (dextrose equivalent, a percentage per direct reduction in terms of glucose in solids, with a glucose of 100). Powder with physical properties between and starch syrup. Maltodextrin is excellent in oil absorption, completely soluble in cold water, difficult to be absorbed, and thus preventing dissolution and caking.
본 발명의 입자화된 이염방지제 조성물은 본 발명의 목적을 저해하지 않는 범위 내에서 제올라이트, 백토, 벤토나이트, 타르크, 규조토 및 이들의 혼합물로 이루어진 군으로부터 선택된 물질을 입자성 개선 등의 목적으로 추가로 함유할 수 있다.The granulated anti-inflammation agent composition of the present invention may add a substance selected from the group consisting of zeolite, white earth, bentonite, tar, diatomaceous earth, and mixtures thereof for the purpose of improving particle size, without impairing the object of the present invention. It may contain.
보다 바람직하게, 본 발명의 입자화된 이염방지제 조성물은 상기 화학식 1로 표시되는 이염방지제 5 내지 80 중량부; 덱스트린 10 내지 90 중량부; 및 제올라이트, 백토, 벤토나이트, 타르크, 규조토 및 이들의 혼합물로 이루어진 군으로부터 선택된 물질 0 내지 30 중량부;를 포함한다.More preferably, the granulated anti-inflammation composition of the present invention is 5 to 80 parts by weight of an anti-inhibitor represented by Formula 1; 10 to 90 parts by weight of dextrin; And 0 to 30 parts by weight of a material selected from the group consisting of zeolite, clay, bentonite, tar, diatomaceous earth, and mixtures thereof.
본 발명의 입자화된 이염방지제 조성물은 예를 들어 다음과 같이 제조될 수 있으나, 이에 한정되는 것은 아니다. 우선, 수평 수직의 혼합기에 말토덱스트린을 넣은 다음 전술한 화학식 1의 이염방지제를 넣어 입자화시킨다. 더욱 구체적으로, 하이스피드믹서, 레디게믹서, 헨셀믹서, 무중력혼합기 등과 같은 연속식이 아닌 혼합기에 말토덱스트린을 10 내지 90 중량부를 넣은 후 액상 이염방지제를 5 내지 80 중량부를 넣고 혼합기를 회전하여 이염방지제를 말토덱스트린에 함침시킨다.The granulated anti-inflammation composition of the present invention may be prepared, for example, as follows, but is not limited thereto. First, maltodextrin is added to a horizontal and vertical mixer, followed by granulation by adding the anti-inflammatory agent of Chemical Formula 1 described above. More specifically, 10 to 90 parts by weight of maltodextrin is added to a non-continuous mixer such as a high speed mixer, a reggae mixer, a Henschel mixer, and a zero gravity mixer, and then, 5 to 80 parts by weight of a liquid anti-inflammatory agent is added, and the anti-inflammatory agent is rotated. Is impregnated into maltodextrin.
기존의 이염방지제 입자화 담체인 실리카 및 제올라이트를 사용하여 입자화시킬 때, 폴리머가 덩어리지는 경우 제올라이트를 계속적으로 투입을 하여도 입자화되지 않고 프리 제올라이트가 생성되어 수율이 극심하게 저하되는 문제가 있다. 그러나 본 발명의 덱스트린를 사용하여 입자화시킬 경우 위와 같은 문제를 해소하고 수율도 유지하며, 물에 대한 용해성의 개선효과를 가져올 수 있는 장점이 있다. 혼합기의 교반속도를 너무 빠르게 하면 마찰열에 의해 이염방지제가 휘발되어 실제 유효성분 함량이 감소되므로 적절하게 조절할 필요가 있으며, 선택적으로 제올라이트, 백토, 벤토나이트, 타르크, 규조토 등의 표면개질제를 0 내지 30 중량부 첨가 하여 입자의 흐름성을 양호하게 할 수도 있다. 또한 부가적으로 입자화된 이염방지제를 건조공정에 통과시킬 수 있다.When the particles are agglomerated using silica and zeolites, which are conventional anti-inflammatory agent granulation carriers, there is a problem in that if the polymer is agglomerated, pre-zeolites are formed without being granulated even though the zeolite is continuously added, the yield is severely reduced. . However, when granulated using the dextrin of the present invention, the above problems are solved and the yield is maintained, and there is an advantage that can bring about an effect of improving solubility in water. If the stirring speed of the mixer is too high, the anti-inflammatory agent is volatilized by frictional heat, and thus the amount of effective active ingredient is reduced. Therefore, it is necessary to appropriately adjust the surface modifiers such as zeolite, clay, bentonite, tark, and diatomaceous earth. By weight part addition, the flowability of a particle | grain can also be made favorable. In addition, the granulated anti-inflammation agent may be passed through a drying process.
이하, 본 발명을 구체적으로 설명하기 위해 실시예 등을 들어 상세하게 설명하기로 한다. 그러나 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 아래에서 상술하는 실시예들에 한정되는 것으로 해석되어져서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해서 제공되어지는 것이다.Hereinafter, the present invention will be described in detail with reference to Examples. However, embodiments according to the present invention may be modified in many different forms, the scope of the present invention should not be construed as limited to the embodiments described below. Embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.
<실시예 1 및 비교예 1-3> 이염방지제 조성물의 제조<Example 1 and Comparative Example 1-3> Preparation of anti-inflammatory agent composition
하기 표 1에 기재된 바와 같은 성분과 함량으로 다음과 같이 제조하였다. 즉, 하이스피드믹서에 말토덱스트린을 넣은 다음, 액상의 이염방지제를 넣고 혼합기를 회전하여 이염방지제를 함침시켰다. 혼합기의 교반속도는 1000-3000 rpm으로 하였다. 이어서, 입자화된 이염방지제를 건조시켜 결과물을 수득하였다. 비교예 1과 비교예 2는 입자화하지 않은 이염방지제를 이온제거수에 용해시킨 예이며, 비교예 3 및 실시예 1은 입자화한 이염방지제 조성물이다. 비교예 3은 미국특허 제6,117,834호에 따라 입자화된 이염방지제 조성물이다. 단위는 중량부이다.To the ingredients and contents as described in Table 1 below were prepared as follows. That is, maltodextrin was added to the high speed mixer, then a liquid anti-inflammatory agent was added and the mixer was rotated to impregnate the anti-inflammatory agent. The stirring speed of the mixer was 1000-3000 rpm. The granulated anti-inflammatory agent was then dried to yield the result. Comparative Example 1 and Comparative Example 2 are examples of dissolving the non-granulated anti-inflammatory agent in deionized water, and Comparative Examples 3 and 1 are granulated anti-inflammatory agent compositions. Comparative Example 3 is an anti-inflammation agent composition granulated according to US Pat. No. 6,117,834. The unit is parts by weight.
상기 표 1에서, 폴리비닐엔옥사이드는 ISP사의 [4-Ethenyl pyridine, homopolymer, N-oxide; aqueous solution]이다.In Table 1, the polyvinyl oxide is ISP [4-Ethenyl pyridine, homopolymer, N-oxide; aqueous solution].
<실험예 1> 이염방지력 평가Experimental Example 1 Evaluation of Disinfection Prevention
실시예 1 및 비교예 1-3에서 얻은 시료를 후술하는 ASTM D5548 평가법에 따라 이염방지력을 평가하였다.The anti-dyeing ability was evaluated according to the ASTM D5548 evaluation method described below, which was obtained in Examples 1 and Comparative Examples 1-3.
11×14 ㎠의 백색 면포와 동일한 크기의 Acid Red151, Direct Blue1 및 Direct Blue90의 염색포를 이용하였다. 터고미터(Terg-o-tometer)에 물(수온 49℃, 경도 110ppm, 3:1 = Ca:Mg)과 일반세제 1 g 및 각각의 시료 0.2 g을 첨가한 후, 여기에 백색면포 및 상기 염색포 3장을 넣어 40 분간 세탁한 후, 20℃의 동일한 경도에서 3분간 헹구고, 자연 건조하였다.Dye cloths of Acid Red 151, Direct Blue 1, and Direct Blue 90 having the same size as 11 × 14 cm 2 white cotton cloth were used. After adding water (water temperature 49 ° C, hardness 110ppm, 3: 1 = Ca: Mg), 1 g of a general detergent and 0.2 g of each sample, a white cotton cloth and the dye were added to a terg-o-tometer. Three pieces of cloth were put and washed for 40 minutes, then rinsed for 3 minutes at the same hardness of 20 ° C, and naturally dried.
상기 면포의 세척 전 및 후를 색차계를 사용하여 DE를 측정한 후, 하기와 같은 수학식에 대입하여 이염도를 계산하였고 그 결과를 표 2에 나타냈다.Before and after washing the cotton cloth was measured DE using a color difference meter, and then substituting the following equation to calculate the degree of dye, the results are shown in Table 2.
상기 수학식 1에서, L은 reflectance을 의미하고, a는 redness/greenness을 의미하며, b는 yellowness/blueness을 의미하고, w는 fabric after washing을 의미하며, o는 fabric before washing을 의미한다.In Equation 1, L means reflectance, a means redness / greenness, b means yellowness / blueness, w means fabric after washing, and o means fabric before washing.
상기 표 2의 결과에서 알 수 있는 바와 같이, 본 발명에 따른 실시예 1의 입자화된 이염방지제 조성물은 같은 중량의 이염방지제를 함유한, 입자화를 시키지 않은 비교예 1의 액상 이염방지제와 거의 성능이 동등함을 확인할 수 있다. 한편 비교예 3의 입자화된 이염방지제는 같은 중량의 이염방지제를 함유한, 입자화를 시키지 않은 비교예 2의 액상 이염방지제에 비해 이염방지력이 상당히 떨어짐을 알 수 있다.As can be seen from the results of Table 2, the granulated anti-inhibitor composition of Example 1 according to the present invention is almost the same as the liquid anti-inflammation agent of Comparative Example 1, which does not granulate, containing the same weight of the anti-inflammation agent You can see that the performance is equivalent. On the other hand, the granulated anti-inflammatory agent of Comparative Example 3 can be seen that the anti-degradation ability is significantly lower than the liquid anti-inflammatory agent of Comparative Example 2 that does not granulate, containing the same weight of the anti-inflammatory agent.
이상과 같이, 본 발명에 따라 덱스트린을 담체로 하여 액상 이염방지제를 입자화한 이염방지제 조성물은 이염방지제의 유효성분을 충분히 함유하고 프리(Free) 담체의 발생이 거의 없어 제조공정비를 절감하고 수율을 상승시킬 수 있을 뿐만 아니라, 담체로 수용해성이 양호한 덱스트린을 사용함으로써 저온세탁에서도 이염방지의 효과를 제대로 발현할 수 있고, 세탁 후 의류에 잔존하지 않는다.As described above, the anti-inflammatory agent composition in which the liquid anti-inflammatory agent is granulated with dextrin as a carrier according to the present invention contains the active ingredient of the anti-inflammatory agent and there is almost no free carrier, thereby reducing the manufacturing process cost and improving the yield. Not only can it be raised, but also dextrin, which has good water solubility as a carrier, can properly express the effect of preventing dye transfer even in low temperature washing, and does not remain in clothes after washing.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050107854A KR100697936B1 (en) | 2005-11-11 | 2005-11-11 | Granulated Anti-Inflammatory Composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050107854A KR100697936B1 (en) | 2005-11-11 | 2005-11-11 | Granulated Anti-Inflammatory Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR100697936B1 true KR100697936B1 (en) | 2007-03-20 |
Family
ID=41563923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020050107854A Expired - Fee Related KR100697936B1 (en) | 2005-11-11 | 2005-11-11 | Granulated Anti-Inflammatory Composition |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR100697936B1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0672104A1 (en) * | 1992-12-03 | 1995-09-20 | Unilever Plc | Protection of adjuncts. |
| KR20050025866A (en) * | 2003-09-08 | 2005-03-14 | 주식회사 엘지생활건강 | Granular dye transfer inhibitor composition suitable for incorporation in a particulate detergent composition |
-
2005
- 2005-11-11 KR KR1020050107854A patent/KR100697936B1/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0672104A1 (en) * | 1992-12-03 | 1995-09-20 | Unilever Plc | Protection of adjuncts. |
| KR20050025866A (en) * | 2003-09-08 | 2005-03-14 | 주식회사 엘지생활건강 | Granular dye transfer inhibitor composition suitable for incorporation in a particulate detergent composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU596240B2 (en) | Machine dishwashing composition | |
| US4756845A (en) | Bleaching compositions | |
| JPH04227696A (en) | Stabilized peroxycarboxylic acid granule | |
| US20180187130A1 (en) | Granulates, Their Use and Washing Agent and Cleaning Agents Containing Same | |
| JPH0198697A (en) | detergent composition | |
| JP2009507122A (en) | Coated peroxycarboxylic acid granules, methods for their preparation and their use in detergents, bleaches or disinfecting applications | |
| US11674113B2 (en) | Co-granules, detergents and cleaning agents and use thereof | |
| US9796954B2 (en) | Dyed coated bleach materials | |
| KR940000437B1 (en) | Built nonionic detergent composition containing stabilized polyethylene terephthalate-polyoxyethylene terephthalate soil release promoting polymer | |
| NO164604B (en) | STABILIZED, DUST-RELEASE-PROMOTING POLYMES OF POLYETHYLENTE REPHALATE AND POLYOXETHYLENTE REPHALATE, PROCEDURE FOR THE PREPARATION OF THESE AND APPLICATION OF THIS. | |
| JP2000096089A (en) | Functionated polyamine | |
| JP2001517730A (en) | Water-soluble dye-complexed polymer as dye transfer inhibitor in laundry detergent and fabric softener compositions | |
| FR2689901A1 (en) | Powdered composition for washing dishes. | |
| JPS60262897A (en) | Granular nonionic detergent composition containing builder | |
| KR100697936B1 (en) | Granulated Anti-Inflammatory Composition | |
| US6262008B1 (en) | Stabilized sodium carbonate peroxyhydrate | |
| US20060079428A2 (en) | Use of new bleach activators in dishwashing detergents | |
| JP5036113B2 (en) | Manufacturing method of granular detergent or its premix | |
| KR20050025866A (en) | Granular dye transfer inhibitor composition suitable for incorporation in a particulate detergent composition | |
| JPH04225097A (en) | Stabilized peroxycarboxylic acid granule | |
| KR20050025865A (en) | Granular dye transfer inhibitor composition suitable for incorporation in a particulate detergent composition | |
| CN101103100B (en) | Product and method of treatment | |
| EP0296813A1 (en) | Powder compositions and detergent compositions | |
| KR101139882B1 (en) | Bleach activators and bleaching compositions containing a mixture of alkyloxime and diamine compounds | |
| KR20050035786A (en) | Detergent composition including granular dye transfer inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20051111 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20060921 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20070213 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20070314 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20070313 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |